Price data is not available
NUO THERAPEUTICS INC NEW by Nuo Therapeutics, Inc.
AURXOTCQB
NUO THERAPEUTICS INC NEW by Nuo Therapeutics fell 52.6% from $2.30 to $1.09, behind the S&P 500's +10.8%. Its worst day was Apr 6 (−19.8%), and its low came Aug 14 at $0.77.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
NUO THERAPEUTICS INC NEW by Nuo Therapeutics closed at its highest level of the year, 2.6% above where the year started.
+4.7% · S&P 500 −0.9%
NUO THERAPEUTICS INC NEW by Nuo Therapeutics shares fell 19.8%, while the S&P 500 rose 0.5%.
Story events cover the past 12 months · Times ET
−19.8%, the year's worst day · S&P 500 +0.5%
NUO THERAPEUTICS INC NEW by Nuo Therapeutics shares fell 17.8%, while the S&P 500 fell 0.7%.
−17.8% · S&P 500 −0.7%
NUO THERAPEUTICS INC NEW by Nuo Therapeutics closed at its lowest level of the year, 66.5% below where the year started.
−7.2% · S&P 500 −0.2%
Where it ended: a close of $1.09 on Nov 11, 2026.
Nothing in the past 12 months.
All AURX earningsNothing in the past 12 months.
All AURX dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AURX and SPY from Benzinga historical bars. Not investment advice.
